Tag: chronic intractable pain
Nalu announces positive results from spinal cord stimulation nPower US clinical...
Nalu Medical has announced the publication of the spinal cord stimulation (SCS) nPower US clinical study in the Pain Physician Journal, reporting on clinical outcomes...
Nalu presents new study data on pain management with PNS and...
Nalu Medical, a company that has miniaturised neurostimulation implants for the management of chronic intractable pain for both peripheral nerve stimulation (PNS) and spinal...
Nalu Medical announces publication of two spinal cord stimulation clinical studies
Nalu Medical—a company working on miniaturised neurostimulation implants for the management of chronic intractable pain via both spinal cord stimulation (SCS) and peripheral nerve...
Saluda Medical receives FDA approval for Evoke SCS system to treat...
Saluda Medical has announced that it has received full approval from the US Food and Drug Administration (FDA) for the Evoke spinal cord stimulation (SCS)...
Passive recharge burst SCS provides sustainable improvements in pain and psychosocial...
Passive recharge burst spinal cord stimulation (B-SCS) can alleviate pain intensity and psychological distress, and improve physical function and health-related quality of life out...
Neuros Medical completes enrolment in QUEST pivotal study of novel post-amputation...
Neuros Medical—a medical device company developing novel high-frequency nerve block technology for patients with intractable post-amputation pain—has announced the completion of enrolment in its pivotal QUEST...
Neuros Medical gains FDA Breakthrough Device designation for Altius nerve block...
Neuros Medical has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for the use of its novel, high-frequency nerve block...
